Evidence map›Paper›PMID 41213135›Full record

ArticleJournal of neurosurgery. Case lessons2025

Hypercalcemia associated with relapsed medulloblastoma due to bone metastasis: illustrative case.

Rikuto Ito, Masayuki Kanamori, Yoshiteru Shimoda, Masahiro Irie, Hidetaka Niizuma, Hirofumi Watanabe, Mika Watanabe, Yonehiro Kanemura, Atsuo Kikuchi, Hidenori Endo

Abstract read
In one paragraph

Article in Journal of neurosurgery. Case lessons, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Fulminant extraneural metastases in MYC-amplified Group 3 medulloblastoma: a pediatric case report.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rikuto ItoDepartment of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai.
Masayuki KanamoriDepartment of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai.
Yoshiteru ShimodaDepartment of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai.
Masahiro IrieDepartment of Pediatrics, Tohoku University Graduate School of Medicine, Sendai.ORCID 0000-0002-9446-6244
Hidetaka NiizumaDepartment of Pediatrics, Tohoku University Graduate School of Medicine, Sendai.ORCID 0000-0002-3161-8968
Hirofumi WatanabeDepartment of Pathology, Tohoku University Hospital, Sendai.ORCID 0000-0002-0253-7122
Mika WatanabeDepartment of Pathology, Tohoku University Hospital, Sendai.
Yonehiro KanemuraDepartment of Biomedical Research and Innovation, Institute for Clinical Research, NHO Osaka National Hospital, Osaka.ORCID 0000-0002-1894-1824
Atsuo KikuchiDepartment of Pediatrics, Tohoku University Graduate School of Medicine, Sendai.ORCID 0000-0003-1002-8739
Hidenori EndoDepartment of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMedulloblastoma can cause extraneural metastasis, particularly to the bones. However, only a few reports have shown that hypercalcemia occurs with medulloblastoma, and there are no reports on hypercalcemia causing consciousness disturbance. OBSERVATIONS: A 17-year-old male patient was treated for medulloblastoma with spinal and intracranial metastasis. He underwent subtotal resection, followed by radiotherapy to the craniospinal axis, posterior fossa, and primary site, as well as high-dose chemotherapy with autologous hematopoietic stem cell transplantation. He achieved complete remission after the initial treatment. However, 30 months after tumor resection, he developed headache, nausea, fatigue, and pain in the limbs and back, followed by consciousness disturbance. He had severe hypercalcemia (17.7 mg/dL) and multiple bone metastases. His symptoms improved with hypercalcemia treatment, and salvage chemotherapy resulted in complete remission of the recurrent disease. LESSONS: Previous studies have not reported consciousness disturbance caused by hypercalcemia due to medulloblastoma bone metastasis. Hypercalcemia causes various symptoms, affecting the neurological, cardiac, and gastrointestinal systems. Some of its symptoms, such as fatigue, nausea, vomiting, and bradycardia, are similar to those of increased intracranial pressure. Therefore, hypercalcemia attributed to bone metastases should be considered in the differential diagnosis of consciousness disturbance during the course of medulloblastoma. https://thejns.org/doi/10.3171/CASE25318.

Indexed as

bone metastasisconsciousness disturbancehypercalcemiamedulloblastoma

Identifiers

PMID41213135
PMCPMC12599380

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.